Accurate interpretation of knee MRI scans relies on expert clinical judgment, often with high variability and limited scalability. Existing radiomic approaches use a fixed set of radiomic features (the signature), selected at the population level and applied uniformly to all patients. While interpretable, these signatures are often too constrained to represent individual pathological variations. As a result, conventional radiomic-based approaches are found to be limited in performance, compared with recent end-to-end deep learning (DL) alternatives without using interpretable radiomic features. We argue that the individual-agnostic nature in current radiomic selection is not central to its intepretability, but is responsible for the poor generalization in our application. Here, we propose a novel radiomic fingerprint framework, in which a radiomic feature set (the fingerprint) is dynamically constructed for each patient, selected by a DL model. Unlike the existing radiomic signatures, our fingerprints are derived on a per-patient basis by predicting the feature relevance in a large radiomic feature pool, and selecting only those that are predictive of clinical conditions for individual patients. The radiomic-selecting model is trained simultaneously with a low-dimensional (considered relatively explainable) logistic regression for downstream classification. We validate our methods across multiple diagnostic tasks including general knee abnormalities, anterior cruciate ligament (ACL) tears, and meniscus tears, demonstrating comparable or superior diagnostic accuracy relative to state-of-the-art end-to-end DL models. More importantly, we show that the interpretability inherent in our approach facilitates meaningful clinical insights and potential biomarker discovery, with detailed discussion, quantitative and qualitative analysis of real-world clinical cases to evidence these advantages.

Positron Emission Tomography / Computed Tomography (PET/CT) plays a critical role in medical imaging, combining functional and anatomical information to aid in accurate diagnosis. However, image quality degradation due to noise, compression and other factors could potentially lead to diagnostic uncertainty and increase the risk of misdiagnosis. When evaluating the quality of a PET/CT image, both low-level features like distortions and high-level features like organ anatomical structures affect the diagnostic value of the image. However, existing medical image quality assessment (IQA) methods are unable to account for both feature types simultaneously. In this work, we propose MS-IQA, a novel multi-scale feature fusion network for PET/CT IQA, which utilizes multi-scale features from various intermediate layers of ResNet and Swin Transformer, enhancing its ability of perceiving both local and global information. In addition, a multi-scale feature fusion module is also introduced to effectively combine high-level and low-level information through a dynamically weighted channel attention mechanism. Finally, to fill the blank of PET/CT IQA dataset, we construct PET-CT-IQA-DS, a dataset containing 2,700 varying-quality PET/CT images with quality scores assigned by radiologists. Experiments on our dataset and the publicly available LDCTIQAC2023 dataset demonstrate that our proposed model has achieved superior performance against existing state-of-the-art methods in various IQA metrics. This work provides an accurate and efficient IQA method for PET/CT. Our code and dataset are available at https://github.com/MS-IQA/MS-IQA/.

The emergence of new-generation artificial intelligence technology has brought numerous innovations to the healthcare field, including telemedicine and intelligent care. However, the artificial intelligent medical device sector still faces significant challenges, such as data privacy protection and algorithm reliability. This study, based on invention patent analysis, revealed the technological innovation trends in the field of artificial intelligent medical devices from aspects such as patent application time trends, hot topics, regional distribution, and innovation players. The results showed that global invention patent applications had remained active, with technological innovations primarily focused on medical image processing, physiological signal processing, surgical robots, brain-computer interfaces, and intelligent physiological parameter monitoring technologies. The United States and China led the world in the number of invention patent applications. Major international medical device giants, such as Philips, Siemens, General Electric, and Medtronic, were at the forefront of global technological innovation, with significant advantages in patent application volumes and international market presence. Chinese universities and research institutes, such as Zhejiang University, Tianjin University, and the Shenzhen Institute of Advanced Technology, had demonstrated notable technological innovation, with a relatively high number of patent applications. However, their overseas market expansion remained limited. This study provides a comprehensive overview of the technological innovation trends in the artificial intelligent medical device field and offers valuable information support for industry development from an informatics perspective.

The objective of this study is to map the global scientific competitive landscape in the field of artificial intelligence (AI) medical devices using scientific data. A bibliometric analysis was conducted using the Web of Science Core Collection to examine global research trends in AI-based medical devices. As of the end of 2023, a total of 55 147 relevant publications were identified worldwide, with 76.6% published between 2018 and 2024. Research in this field has primarily focused on AI-assisted medical image and physiological signal analysis. At the national level, China (17 991 publications) and the United States (14 032 publications) lead in output. China has shown a rapid increase in publication volume, with its 2023 output exceeding twice that of the U.S.; however, the U.S. maintains a higher average citation per paper (China: 16.29; U.S.: 35.99). At the institutional level, seven Chinese institutions and three U.S. institutions rank among the global top ten in terms of publication volume. At the researcher level, prominent contributors include Acharya U Rajendra, Rueckert Daniel and Tian Jie, who have extensively explored AI-assisted medical imaging. Some researchers have specialized in specific imaging applications, such as Yang Xiaofeng (AI-assisted precision radiotherapy for tumors) and Shen Dinggang (brain imaging analysis). Others, including Gao Xiaorong and Ming Dong, focus on AI-assisted physiological signal analysis. The results confirm the rapid global development of AI in the medical device field, with "AI + imaging" emerging as the most mature direction. China and the U.S. maintain absolute leadership in this area-China slightly leads in publication volume, while the U.S., having started earlier, demonstrates higher research quality. Both countries host a large number of active research teams in this domain.

Obesity is associated with functional alterations in the brain. Although spatial organisation changes in the brains of individuals with obesity have been widely studied, the temporal dynamics in their brains remain poorly understood. Therefore, in this study, we investigated variations in the intrinsic neural timescale (INT) across different degrees of obesity using resting-state functional and diffusion magnetic resonance imaging data from the enhanced Nathan Kline Institute Rockland Sample database. We examined the relationship between the INT and obesity phenotypes using supervised machine learning, controlling for age and sex. To further explore the structure-function characteristics of these regions, we assessed the modular network properties by analysing the participation coefficients and within-module degree derived from the structure-function coupling matrices. Finally, the INT values of the identified regions were used to predict eating behaviour traits. A significant negative correlation was observed, particularly in the default mode, limbic and reward networks. We found a negative association with the participation coefficients, suggesting that shorter INT values in higher-order association areas are related to reduced network integration. Moreover, the INT values of these identified regions moderately predicted eating behaviours, underscoring the potential of the INT as a candidate marker for obesity and eating behaviours. These findings provide insight into the temporal organisation of neural activity in obesity, highlighting the role of specific brain networks in shaping behavioural outcomes.

The study aims to utilize interpretable machine learning models to predict the risk of myasthenia gravis onset in thymoma patients and investigate the intrinsic correlations and causal relationships between them. A comprehensive retrospective analysis was conducted on 172 thymoma patients diagnosed at two medical centers between 2018 and 2024. The cohort was bifurcated into a training set (n = 134) and test set (n = 38) to develop and validate risk predictive models. Radiomic and deep features were extracted from tumor regions across three CT phases: non-enhanced, arterial, and venous. Through rigorous feature selection employing Spearman's rank correlation coefficient and LASSO (Least Absolute Shrinkage and Selection Operator) regularization, 12 optimal imaging features were identified. These were integrated with 11 clinical parameters and one pathological subtype variable to form a multi-dimensional feature matrix. Six machine learning algorithms were subsequently implemented for model construction and comparative analysis. We utilized SHAP (SHapley Additive exPlanation) to interpret the model and employed doubly robust learner to perform a potential causal analysis between thymoma and myasthenia gravis (MG). All six models demonstrated satisfactory predictive capabilities, with the support vector machine (SVM) model exhibiting superior performance on the test cohort. It achieved an area under the curve (AUC) of 0.904 (95% confidence interval [CI] 0.798-1.000), outperforming other models such as logistic regression, multilayer perceptron (MLP), and others. The model's predictive result substantiates the strong correlation between thymoma and MG. Additionally, our analysis revealed the existence of a significant causal relationship between them, and high-risk tumors significantly elevated the risk of MG by an average treatment effect (ATE) of 9.2%. This implies that thymoma patients with types B2 and B3 face a considerably high risk of developing MG compared to those with types A, AB, and B1. The model provides a novel and effective tool for evaluating the risk of MG development in patients with thymoma. Furthermore, correlation and causal analysis have unveiled pathways that connect tumor to the risk of MG, with a notably higher incidence of MG observed in high risk pathological subtypes. These insights contribute to a deeper understanding of MG and drive a paradigm shift in medical practice from passive treatment to proactive intervention.

Differentiating intrahepatic cholangiocarcinoma (ICC) from hepatocellular carcinoma (HCC) is essential for selecting the most effective treatment strategies. However, traditional imaging modalities and serum biomarkers often lack sufficient specificity. Radiomics, a sophisticated image analysis approach that derives quantitative data from medical imaging, has emerged as a promising non-invasive tool. To systematically review and meta-analyze the radiomics diagnostic accuracy in differentiating ICC from HCC. PubMed, EMBASE, and Web of Science databases were systematically searched through January 24, 2025. Studies evaluating radiomics models for distinguishing ICC from HCC were included. Assessing the quality of included studies was done by using Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) and METhodological RadiomICs Score tools. Pooled sensitivity, specificity, and area under the curve (AUC) were calculated using a bivariate random-effects model. Subgroup and publication bias analyses were also performed. 12 studies with 2541 patients were included, with 14 validation cohorts entered into meta-analysis. The pooled sensitivity and specificity of radiomics models were 0.82 (95% CI: 0.76-0.86) and 0.90 (95% CI: 0.85-0.93), respectively, with an AUC of 0.88 (95% CI: 0.85-0.91). Subgroup analyses revealed variations based on segmentation method, software used, and sample size, though not all differences were statistically significant. Publication bias was not detected. Radiomics demonstrates high diagnostic accuracy in distinguishing ICC from HCC and offers a non-invasive adjunct to conventional diagnostics. Further prospective, multicenter studies with standardized workflows are needed to enhance clinical applicability and reproducibility.

Respiratory disorders cause approximately 4 million deaths annually worldwide, making them the third leading cause of mortality. Early detection is critical to improving survival rates and recovery outcomes. However, chest X-rays require expertise, and computational intelligence provides valuable support to improve diagnostic accuracy and support medical professionals in decision-making. This study presents an automated system to classify respiratory diseases using three diverse datasets comprising 18,000 chest X-ray images and masks, categorized into six classes. Image preprocessing techniques, such as resizing for input standardization and CLAHE for contrast enhancement, were applied to ensure uniformity and improve the visual quality of the images. Albumentations-based augmentation methods addressed class imbalances, while bitwise segmentation focused on extracting the region of interest (ROI). Furthermore, clinically handcrafted feature extraction enabled the accurate identification of 20 critical clinical features essential for disease classification. The K-nearest neighbors (KNN) graph construction technique was utilized to transform tabular data into graph structures for effective node classification. We employed feature analysis to identify critical attributes that contribute to class predictions within the graph structure. Additionally, the GNNExplainer was utilized to validate these findings by highlighting significant nodes, edges, and features that influence the model's decision-making process. The proposed model, Chest X-ray Graph Neural Network (CHXGNN), a robust Graph Neural Network (GNN) architecture, incorporates advanced layers, batch normalization, dropout regularization, and optimization strategies. Extensive testing and ablation studies demonstrated the model's exceptional performance, achieving an accuracy of 99.56 %. Our CHXGNN model shows significant potential in detecting and classifying respiratory diseases, promising to enhance diagnostic efficiency and improve patient outcomes in respiratory healthcare.

Artificial intelligence (AI) is a disruptive technology that is currently finding widespread application after having long been confined to the domain of specialists. In urology, in particular, new fields of application are continuously emerging, which are being studied both in preclinical basic research and in clinical applications. Potential applications include image recognition in the operating room or interpreting images from radiology and pathology, the automatic measurement of urinary stones and radiotherapy. Certain medical devices, particularly in the field of AI-based predictive biomarkers, have already been incorporated into international guidelines. In addition, AI is playing an increasingly more important role in administrative tasks and is expected to lead to enormous changes, especially in the outpatient sector. For urologists, it is becoming increasingly more important to engage with this technology, to pursue appropriate training and therefore to optimally implement AI into the treatment of patients and in the management of their practices or hospitals.

The International Society of Urological Pathology (ISUP) grading of prostate cancer (PCa) is a crucial factor in the management and treatment planning for PCa patients. An accurate and non-invasive assessment of the ISUP grading group could significantly improve biopsy decisions and treatment planning. The use of PSMA-PET/CT radiomics for predicting ISUP has not been widely studied. The aim of this study is to investigate the role of ⁶⁸Ga-PSMA PET/CT radiomics in predicting the ISUP grading of primary PCa. This study included 415 PCa patients who underwent ⁶⁸Ga-PSMA PET/CT scans before prostate biopsy or radical prostatectomy. Patients were from three centers: Xiangya Hospital, Central South University (252 cases), Qilu Hospital of Shandong University (External Validation 1, 108 cases), and Qingdao University Medical College (External Validation 2, 55 cases). Xiangya Hospital cases were split into training and testing groups (1:1 ratio), with the other centers serving as external validation groups. Feature selection was performed using Minimum Redundancy Maximum Relevance (mRMR) and Least Absolute Shrinkage and Selection Operator (LASSO) algorithms. Eight machine learning classifiers were trained and tested with ten-fold cross-validation. Sensitivity, specificity, and AUC were calculated for each model. Additionally, we combined the radiomic features with maximum Standardized Uptake Value (SUVmax) and prostate-specific antigen (PSA) to create prediction models and tested the corresponding performances. The best-performing model in the Xiangya Hospital training cohort achieved an AUC of 0.868 (sensitivity 72.7%, specificity 96.0%). Similar trends were seen in the testing cohort and external validation centers (AUCs: 0.860, 0.827, and 0.812). After incorporating PSA and SUVmax, a more robust model was developed, achieving an AUC of 0.892 (sensitivity 77.9%, specificity 96.0%) in the training group. This study established and validated a radiomics model based on ⁶⁸Ga-PSMA PET/CT, offering an accurate, non-invasive method for predicting ISUP grades in prostate cancer. A multicenter design with external validation ensured the model's robustness and broad applicability. This is the largest study to date on PSMA radiomics for predicting ISUP grades. Notably, integrating SUVmax and PSA metrics with radiomic features significantly improved prediction accuracy, providing new insights and tools for personalized diagnosis and treatment.